Gold prices buoyed by tariff fears; US duties on 1-kilo bars spur supply concerns
Investing.com - Oscar Health (NYSE: OSCR) reported second quarter EPS of $-0.89, $0.05 worse than the analyst estimate of $-0.84. Revenue for the quarter came in at $2.86B versus the consensus estimate of $2.92B.
Guidance
Oscar Health sees FY 2025 revenue of $12.00B-$12.20B versus the analyst consensus of $12.01B.
Oscar Health’s stock price closed at $13.82. It is down -19.23% in the last 3 months and down -17.25% in the last 12 months.
Oscar Health saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Oscar Health’s stock price’s past reactions to earnings here.
According to InvestingPro, Oscar Health’s Financial Health score is "great performance".
Check out Oscar Health’s recent earnings performance, and Oscar Health’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar